Care of patients with Phenylketonuria (PKU) in Germany - a claims data analysis from 2013 to 2023. [PDF]
Boehnke A +5 more
europepmc +1 more source
Funktion und Fehlfunktion der Phenylalaninhydroxylase in Abhängigkeit von Genotyp, metabolischem Status und Therapie mit dem pharmakologischen Chaperon Tetrahydrobiopterin [PDF]
Staudigl, Michael
core +1 more source
Protein and Micronutrient Intake After Two Years of Sapropterin Treatment in PKU. [PDF]
Yilmaz Nas O +7 more
europepmc +1 more source
Phenylketonuria in Saudi Arabia: An Overview of Diagnosis, Genetics, and Therapeutic Strategies. [PDF]
Tayeb FJ, Mir R, Alatawi S.
europepmc +1 more source
Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature Review. [PDF]
Jones H, Strehle EM.
europepmc +1 more source
Access to orphan drugs in adults with inherited metabolic diseases in Switzerland: a single-center retrospective cohort study. [PDF]
Antoni G +4 more
europepmc +1 more source
Quality of life after diet liberalization in individuals with phenylketonuria treated with Pegvaliase. [PDF]
Cazzorla C +8 more
europepmc +1 more source
Global Trends in Phenylketonuria Treatment Research, 2000-2025: Bibliometric Analysis. [PDF]
Yang S, Song K, Chen Q, Jiang J, Wang L.
europepmc +1 more source
Development of a face-validated conceptual model structure for economic evaluation in phenylketonuria, through expert elicitation. [PDF]
Muntau AC +14 more
europepmc +1 more source
Two-Year Outcomes of Sapropterin Treatment in Children with Phenylketonuria: A Longitudinal Observational Study of Metabolic, Dietary, and Psychosocial Effects. [PDF]
Yilmaz Nas O +7 more
europepmc +1 more source

